Viral cancerogenesis of head and neck tumors

被引:0
作者
Wentzensen, N [1 ]
Doeberitz, MV [1 ]
机构
[1] Univ Heidelberg, Inst Pathol, Abt Mol Pathol, D-69120 Heidelberg, Germany
来源
PATHOLOGE | 2004年 / 25卷 / 01期
关键词
head and neck cancer; HPV; EBV; tonsillar carcinoma; nasopharyngeal carcinoma;
D O I
10.1007/s00292-003-0669-y
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Approximately 15% of malignant diseases are caused by infectious agents. Human papilloma viruses (HPV) can be frequently found in oral carcinomas, especially tonsillar cancer. A group of HPV-infected tumors shows clear signs for a virally induced transformation process: high-risk HPVs can be detected in all tumor cells, the viral oncogenes E6 and E7 are constantly expressed and lead to upregulation of cellular p16(INK4a), a cyclin-dependent kinase inhibitor. The patients frequently lack typical risk factors associated with head and neck cancers such as drinking and smoking. Epstein-Barr viruses (EBV) are associated with lymphoproliferative disorders and cause nasopharyngeal carcinoma (NPC). NPC has a high incidence in some East Asian countries. In this review, the molecular pathogenesis of HPV- and EBV-associated malignancies are described and the clinical relevance of the presented findings is discussed.
引用
收藏
页码:21 / 30
页数:10
相关论文
共 44 条
  • [1] Human papillomavirus in larynx
    Aaltonen, LM
    Rihkanen, H
    Vaheri, A
    [J]. LARYNGOSCOPE, 2002, 112 (04) : 700 - 707
  • [2] Procedure for immunocytochemical of P16INK4A antigen in thin-layer, liquid-based specimens
    Bibbo, M
    Klump, WJ
    DeCecco, J
    Kovatich, AJ
    [J]. ACTA CYTOLOGICA, 2002, 46 (01) : 25 - 29
  • [3] High risk HPV types are frequently detected in potentially malignant and malignant oral lesions, but not in normal oral mucosa
    Bouda, M
    Gorgoulis, VG
    Kastrinakis, NG
    Giannoudis, A
    Tsoli, E
    Danassi-Afentaki, D
    Foukas, P
    Kyroudi, A
    Laskaris, G
    Herrington, CS
    Kittas, C
    [J]. MODERN PATHOLOGY, 2000, 13 (06) : 644 - 653
  • [4] EBV specific antibody-based and DNA-BASED assays in serologic diagnosis of nasopharyngeal carcinoma
    Chan, KH
    Gu, YL
    Ng, F
    Ng, PS
    Seto, WH
    Sham, JST
    Chua, D
    Wei, W
    Chen, YL
    Luk, W
    Zong, YS
    Ng, MH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 105 (05) : 706 - 709
  • [5] Assessing the risk of nasopharyngeal carcinoma on the basis of EBV antibody spectrum
    Cheng, WM
    Chan, KH
    Chen, HL
    Luo, RX
    Ng, SP
    Luk, W
    Zheng, BJ
    Ji, MF
    Liang, JS
    Sham, JST
    Wang, DK
    Zong, YS
    Ng, MH
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (04) : 489 - 492
  • [6] Centrosome abnormalities, genomic instability and carcinogenic progression
    Duensing, S
    Münger, K
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (02): : M81 - M88
  • [7] Papillomavirus vaccines in clinical trials
    Galloway, DA
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (08) : 469 - 475
  • [8] Human papillomavirus DNA in oral mucosal lesions
    Giovannelli, L
    Campisi, G
    Lama, A
    Giambalvo, O
    Osborn, J
    Margiotta, V
    Ammatuna, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (06) : 833 - 836
  • [9] Gastric cancer
    Hohenberger, P
    Gretschel, S
    [J]. LANCET, 2003, 362 (9380) : 305 - 315
  • [10] Hubbard RA, 2003, ARCH PATHOL LAB MED, V127, P940